PTC Therapeutics | Aktywa

Cena Akcji
70.97
Dzienna Zmiana
0.47 0.67%
Miesięcznie
-6.90%
Rocznie
40.93%
Q1 Prognozy TE
68.47




Aktywa Zmiana Data
Acadia Pharmaceuticals USD 1.33B 105.22M 2025-09
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Amgen USD 90.59B 445M 2025-12
BioCryst Pharmaceuticals USD 446.42M 10.76M 2025-09
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Cytokinetics USD 1.44B 210.92M 2025-09
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Esperion Therapeutics USD 364.02M 16.93M 2025-09
Gilead Sciences USD 59.02B 490M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Ionis Pharmaceuticals USD 3.03B 47.96M 2025-09
Ironwood Pharmaceuticals USD 396.06M 53.12M 2025-09
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Novartis USD 107.29B 2.89B 2025-09
Pfizer USD 208.73B 2.64B 2025-09
PTC Therapeutics USD 2.9B 255.07M 2025-12
Puma Biotechnology USD 202.86M 7.95M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
TG Therapeutics USD 1.03B 322.41M 2025-09
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12
Xencor USD 868.81M 10.61M 2025-09


PTC Therapeutics Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.